More about Regeneron Pharmaceuticals, Inc.
Regulatory Filings for Regeneron Pharmaceuticals, Inc.
Fundamentals for Regeneron Pharmaceuticals, Inc.
Not Wall Street, But AI: The Real Force Democratizing Finance Across America
When Flooding Pays: A New Financial Bet
Breakfast for Life How Local Diners and Hardware Stores are Outsmarting Amazon
Before They Can Walk, They're Invested: How Trump Accounts Are Transforming Financial Culture
Regulatory Filings for Regeneron Pharmaceuticals, Inc.
Recent filings by Regeneron Pharmaceuticals, Inc.
| Published | Title | Summary |
|---|---|---|
| 2026-04-29 06:54:54 | 10-Q - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer) | Quarterly Report SEC-10-Q filed by Regeneron Pharmaceuticals, Inc. on 2026-04-29... |
| 2026-04-29 06:50:22 | 8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer) | Item 2.02: Results of Operations and Financial Condition Item 9.01:... |
| 2026-04-08 07:05:58 | 8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer) | Item 2.02: Results of Operations and Financial Condition... |
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst technicals.
Latest Regulatory Filings for SP5
Companies with the best and the worst fundamentals.
The Appalachian Energy Reboot: Inside the Unexpected Nuclear Startup Boom
Theatrical Finance: Credit Unions Use Drama to Attract Youth
Fraud, Delays, and High Fees—Gone: The Underrated Fintech Shift Reshaping U.S. Local Economies
